Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.

Hankins CA, Koulla-Shiro S, Kilmarx P, Ferrari G, Schechter M, Kane CT, Venter F, Boucher CA, Ross AL, Zewdie D, Eholié SP, Katabira E.

Antivir Ther. 2017;22(2):179-184. doi: 10.3851/IMP3165. Epub 2017 Apr 7.

PMID:
28387654
2.

Getting pregnant in HIV clinical trials: women's choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials.

Serris A, Zoungrana J, Diallo M, Toby R, Mpoudi Ngolle M, Le Gac S, Coutherut J, Cournil A, De Beaudrap P, Koulla-Shiro S, Delaporte E, Ciaffi L.

HIV Clin Trials. 2016 Nov;17(6):233-241. Epub 2016 Nov 1.

PMID:
27801628
3.

Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.

Galy A, Ciaffi L, Le Moing V, Eymard-Duvernay S, Abessolo H, Toby R, Ayangma L, Le Gac S, Mpoudi-Etame M, Koulla-Shiro S, Delaporte E, Cournil A; 2LADY Study Group..

Antivir Ther. 2016;21(6):547-552. doi: 10.3851/IMP3030. Epub 2016 Feb 16.

PMID:
26882335
4.

Evolution of renal function in African patients initiating second-line antiretroviral treatment: findings from the ANRS 12169 2LADY trial.

Cournil A, Hema A, Eymard-Duvernay S, Ciaffi L, Badiou S, Kabore FN, Diouf A, Ayangma L, Le Moing V, Reynes J, Koulla-Shiro S, Delaporte E; 2LADY Study Group..

Antivir Ther. 2016 Oct 5. doi: 10.3851/IMP3097. [Epub ahead of print]

PMID:
27705950
5.

Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City.

Nzalie RN, Gonsu HK, Koulla-Shiro S.

Int J Microbiol. 2016;2016:3240268. doi: 10.1155/2016/3240268. Epub 2016 Sep 7.

6.

Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.

Bigna JJ, Plottel CS, Koulla-Shiro S.

Infect Dis Poverty. 2016 Sep 5;5(1):85. doi: 10.1186/s40249-016-0179-9.

7.

Prevalence and incidence of pulmonary hypertension among HIV-infected people in Africa: a systematic review and meta-analysis.

Bigna JJ, Nansseu JR, Um LN, Noumegni SR, Simé PS, Aminde LN, Koulla-Shiro S, Noubiap JJ.

BMJ Open. 2016 Aug 23;6(8):e011921. doi: 10.1136/bmjopen-2016-011921.

8.

Cross-sectional assessment of three commonly used measures of adherence to combination antiviral therapy in a resource limited setting.

Luma HN, Mbatchou Ngahane BH, Mapoure YN, Mengjo NB, Temfack E, Joko HA, Asongalem EA, Koulla-Shiro S.

Int J STD AIDS. 2017 Jan;28(1):69-76. doi: 10.1177/0956462415627394. Epub 2016 Jul 11.

PMID:
26748336
9.

HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment.

Bigna JJ, Sime PS, Koulla-Shiro S.

AIDS Res Ther. 2015 Nov 11;12:36. doi: 10.1186/s12981-015-0078-3. eCollection 2015. Review.

10.

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon.

Ndawinz JD, Anglaret X, Delaporte E, Koulla-Shiro S, Gabillard D, Minga A, Costagliola D, Supervie V.

Bull World Health Organ. 2015 Aug 1;93(8):521-8. doi: 10.2471/BLT.14.147892. Epub 2015 Jun 1.

11.

Resistance pattern of enterobacteriaceae isolates from urinary tract infections to selected quinolones in Yaoundé.

Lyonga EE, Toukam M, Nkenfou C, Gonsu HK, Assoumou MC, Mesembe MT, Eyoh AB, Ikomey GM, Ndze VN, Koulla-Shiro S.

Pan Afr Med J. 2015 Jun 9;21:105. doi: 10.11604/pamj.2015.21.105.5469. eCollection 2015.

12.

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.

Ciaffi L, Koulla-Shiro S, Sawadogo A, le Moing V, Eymard-Duvernay S, Izard S, Kouanfack C, Ngom Gueye NF, Fobang AA, Reynes J, Calmy A, Delaporte E; 2LADY Study Group..

AIDS. 2015 Jul 31;29(12):1473-81. doi: 10.1097/QAD.0000000000000709.

13.

Early Mortality during Initial Treatment of Tuberculosis in Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Retrospective Cohort Study (2006-2013).

Bigna JJ, Noubiap JJ, Agbor AA, Plottel CS, Billong SC, Ayong AP, Koulla-Shiro S.

PLoS One. 2015 Jul 27;10(7):e0132394. doi: 10.1371/journal.pone.0132394. eCollection 2015.

14.

Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon.

Boullé C, Kouanfack C, Laborde-Balen G, Boyer S, Aghokeng AF, Carrieri MP, Kazé S, Dontsop M, Mben JM, Koulla-Shiro S, Peytavin G, Spire B, Delaporte E, Laurent C; Stratall ANRS 12110ESTHER Study Group..

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):355-64. doi: 10.1097/QAI.0000000000000604.

PMID:
26181708
15.

Characteristics of patients co-infected with HIV at the time of inpatient tuberculosis treatment initiation in Yaoundé, Cameroon: a tertiary care hospital-based cross-sectional study.

Agbor AA, Bigna JJ, Plottel CS, Billong SC, Tejiokem MC, Ekali GL, Noubiap JJ, Toby R, Abessolo H, Koulla-Shiro S.

Arch Public Health. 2015 May 4;73(1):24. doi: 10.1186/s13690-015-0075-y. eCollection 2015.

16.

Benefits of task-shifting HIV care to nurses in terms of health-related quality of life in patients initiating antiretroviral therapy in rural district hospitals in Cameroon [Stratall Agence Nationale de Recherche sur le SIDA (ANRS) 12110/Ensemble pour une Solidarité Thérapeutique Hospitalière en Réseau (ESTHER) substudy].

Suzan-Monti M, Blanche J, Boyer S, Kouanfack C, Delaporte E, Bonono RC, Carrieri PM, Protopopescu C, Laurent C, Spire B; Stratall ANRS 12110/ESTHER Study Group..

HIV Med. 2015 May;16(5):307-18. doi: 10.1111/hiv.12213. Epub 2015 Feb 27.

17.

Factors associated with non-adherence to scheduled medical follow-up appointments among Cameroonian children requiring HIV care: a case-control analysis of the usual-care group in the MORE CARE trial.

Bigna JJ, Noubiap JJ, Plottel CS, Kouanfack C, Koulla-Shiro S.

Infect Dis Poverty. 2014 Dec 3;3(1):44. doi: 10.1186/2049-9957-3-44. eCollection 2014.

18.

Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.

Lê MP, Landman R, Koulla-Shiro S, Charpentier C, Sow PS, Diallo MB, Ngom Gueye NF, Ngolle M, Le Moing V, Eymard-Duvernay S, Benalycherif A, Delaporte E, Girard PM, Peytavin G; DAYANA Study Group..

J Antimicrob Chemother. 2015 May;70(5):1517-21. doi: 10.1093/jac/dku532. Epub 2015 Jan 11.

PMID:
25583749
19.

A comparative study of the diagnostic methods for Group A streptococcal sore throat in two reference hospitals in Yaounde, Cameroon.

Gonsu HK, Bomki CM, Djomou F, Toukam M, Ndze VN, Lyonga EE, Mbakop CD, Koulla-Shiro S.

Pan Afr Med J. 2015 Feb 17;20:139. doi: 10.11604/pamj.2015.20.139.4810. eCollection 2015.

20.

Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).

Agbor AA, Bigna JJ, Billong SC, Tejiokem MC, Ekali GL, Plottel CS, Noubiap JJ, Abessolo H, Toby R, Koulla-Shiro S.

PLoS One. 2014 Dec 15;9(12):e115211. doi: 10.1371/journal.pone.0115211. eCollection 2014.

Supplemental Content

Loading ...
Support Center